Macrogenics (MGNX) Retained Earnings (2012 - 2026)
Macrogenics (MGNX) reported Retained Earnings of -$1.3 billion for Q1 2026, down 5.81% year-over-year from -$1.4 billion in Q1 2025, and down 2.96% quarter-over-quarter from -$1.2 billion in Q4 2025.
Macrogenics (MGNX) Retained Earnings (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Retained Earnings data on file, last reported at -$1.3 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$1.3 billion, down 5.81% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.3 billion (down 5.81% YoY), and the FY2025 annual result was -$1.2 billion, down 6.38% from the prior year.
- Retained Earnings declined to -$1.3 billion in Q1 2026 per MGNX's latest filing, from -$1.2 billion in the prior quarter.
- Over five years, Retained Earnings peaked at -$1.0 billion in Q1 2022 and troughed at -$1.3 billion in Q1 2026.
- A 5-year average of -$1.2 billion and a median of -$1.2 billion in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings retreated 26.4% in 2022, then grew 4.5% in 2023.
- A 5-year view of Retained Earnings shows it stood at -$1.1 billion in 2022, then decreased by 0.83% to -$1.1 billion in 2023, then fell by 6.07% to -$1.2 billion in 2024, then retreated by 6.38% to -$1.2 billion in 2025, then dropped by 2.96% to -$1.3 billion in 2026.
- Business Quant data shows MGNX's Retained Earnings at -$1.3 billion in Q1 2026, -$1.2 billion in Q4 2025, and -$1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | -1.28 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.28 Bn |
| Dec 31, 2025 | -1.24 Bn |
| Sep 30, 2025 | -1.23 Bn |
| Jun 30, 2025 | -1.25 Bn |
| Mar 31, 2025 | -1.21 Bn |
| Dec 31, 2024 | -1.17 Bn |
| Sep 30, 2024 | -1.15 Bn |
| Jun 30, 2024 | -1.21 Bn |
| Mar 31, 2024 | -1.15 Bn |
| Dec 31, 2023 | -1.10 Bn |
| Sep 30, 2023 | -1.06 Bn |
| Jun 30, 2023 | -1.07 Bn |
| Mar 31, 2023 | -1.13 Bn |
| Dec 31, 2022 | -1.09 Bn |
| Sep 30, 2022 | -1.11 Bn |
| Jun 30, 2022 | -1.08 Bn |
| Mar 31, 2022 | -1.04 Bn |
| Dec 31, 2021 | -973.94 Mn |
| Sep 30, 2021 | -915.91 Mn |
| Jun 30, 2021 | -863.03 Mn |